In this installment of our Double Play series, our two, thirty-minute programs cover depression and substance abuse. Experts differ on whether lawyers are more prone to depression than others who work in equally high-stress occupations such as doctors. But one thing is clear: the stigma associated with depression is one of the reasons lawyers may not get help when they need it. Is an ancient virus the reason humans are susceptible to substance use disorders? How has modern medicine changed the way we treat substance use disorders? This program answers these important questions so that today's lawyers have the tools they need to help themselves or a colleague.
Joseph Milowic III, Partner, Quinn Emanuel Urquhart & Sullivan LLP, New York, NY
Houman Ehsan, Partner, O’Melveny & Myers LLP, Los Angeles, CA
Joseph is a partner at Quinn Emanuel Urquhart & Sullivan, LLP in New York City. He is also a founder of the Lawyers Depression Project (LDP), a grassroots project aimed at addressing depression and other mental health issues in the legal profession. In 2018, Mr. Milowic was selected by his peers as a New York Metro "Super Lawyer" in Intellectual Property. He has also been selected as a Global Fellow by the Federal Circuit Bar Association in recognition of his “commitment to leadership and cooperation in the global legal community.”
Houman holds a JD, MD, and an MBA, a combination that allows him to focus his practice on the nexus of medicine, business, and the law. As an attorney–physician, he provides clients with legal and factual analysis of complex medical and scientific issues arising from products liability and healthcare litigation defense, healthcare due diligence, and healthcare financial arrangements. He has extensive experience working with expert witnesses in both products liability and general healthcare litigation settings. And within O’Melveny, Houman himself is recognized as an in-house expert, called on to translate the intricacies of the healthcare and life-sciences industries into practical advice for fellow litigators. He counsels clients ranging from biopharmaceutical, to managed health care, to technology companies through deposition and litigation strategies.